We detected no significant difference in weight loss, clinical disease score, or mortality between mice primed with ZIKV and treated with anti-CD4 Ab or isotype control Ab for 30 days prior to secondary ZIKV infection (S7E and S7F Fig). This evidence concerns the gene CD4 and Zika virus infectious disease.